Roche submits "ultrasensitive" HIV test for FDA approval
This article was originally published in Clinica
Executive Summary
Nearly a year later than originally planned, Roche Molecular Systems has finally submitted a new test for FDA approval which it claims will be the most sensitive method available for monitoring HIV levels in infected patients.